Home
About
Overview
Sharing Data
ORCID
Help
History (27)
Osteoimmunology: a brief introduction.
AAV9 delivering a modified human Mullerian inhibiting substance as a gene therapy in patient-derived xenografts of ovarian cancer.
Nuclear physics (of the cell, not the atom).
Tissue-restricted genome editing in vivo specified by microRNA-repressible anti-CRISPR proteins.
Precision medicine: lessons learned from the SHIVA trial.
See All 27 Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Precision medicine: lessons learned from the SHIVA trial.
Weiss GJ. Precision medicine: lessons learned from the SHIVA trial. Lancet Oncol. 2015 Dec; 16(16):e580.
View in:
PubMed
subject areas
Antineoplastic Agents
Biomarkers, Tumor
Female
Gene Expression Profiling
Humans
Male
Molecular Diagnostic Techniques
Molecular Targeted Therapy
Neoplasms
Precision Medicine
authors with profiles
Glen Weiss MD, MBA